PLOS ONE | www.plosone.org
May 2013 | Volume 8 | Issue 5 | e63476
International Journal of Current Research Vol. 10, Issue, 04, pp.68266-68270, April, 2018
ISSN: 0975-833X
A Consumer Guide
Printed 2006
Revised 2007, 2008, 2011, 2014, and 2015
Specific Issues and a Model of Care
Accessed; 08.10.2019
Journal of Virus Eradication 2016; 2 (Supplement 4): 1–6
Review
DHS Working Papers No. 110 | Zimbabwe Working Papers No. 11
International Journal of Infectious Diseases 46 (2016) 56–60
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
In resource restriced countries
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and ...its administration to the patient. There is a risk of error in each process in this “transfusion chain” and a failure at any of these stages can have serious implications for the recipients of blood and blood products. Thus, while blood transfusion can be life-saving, there are associated risks, particularly the transmission of bloodborne infections.
Screening for transfusion-transmissible infections (TTIs) to exclude blood donations at risk of transmitting infection from donors to recipients is a critical part of the process of ensuring that transfusion is as safe as possible. Effective screening for evidence of the presence of the most common and dangerous TTIs can reduce the risk of transmission to very low levels.
more
Review
S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968